🇨🇦 DL-3-n-butylphthalide in Canada

DL-3-n-butylphthalide (DL-3-n-butylphthalide) regulatory status in Canada.

Marketing authorisation

DL-3-n-butylphthalide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DL-3-n-butylphthalide approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for DL-3-n-butylphthalide in Canada?

First Hospital of China Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.